Transition to a new regulatory framework follow up

Ref: MRA I/8/10 Vol I (32)

31 August 2020

In terms of Section 24(2) of the Medicines and Related Substances Act of 2013, an applicant shall be a company registered, licensed, or operating in Botswana. Given the feedback the Authority has received concerning the enforcement of this clause, we have suspended the implementation while we review and conduct further consultation.

Download Now

File name: Transition-to-a-new-regulatory-framework-follow-up.pdf

3792 326